Harmony Biosciences
HRMYApprovedHarmony Biosciences is a publicly traded, patient-centric biopharmaceutical company dedicated to advancing treatments for rare neurological disorders. The company has achieved commercial success with WAKIX® for narcolepsy and is actively expanding its pipeline into new indications and rare epilepsies. With a reiterated 2026 net revenue guidance of over $1 billion, Harmony is demonstrating strong financial performance and strategic growth in the neurology space.
HRMY · Stock Price
Historical price data
AI Company Overview
Harmony Biosciences is a publicly traded, patient-centric biopharmaceutical company dedicated to advancing treatments for rare neurological disorders. The company has achieved commercial success with WAKIX® for narcolepsy and is actively expanding its pipeline into new indications and rare epilepsies. With a reiterated 2026 net revenue guidance of over $1 billion, Harmony is demonstrating strong financial performance and strategic growth in the neurology space.
Technology Platform
Patient-focused drug development model that systematically incorporates patient insights to inform clinical research program design and execution.
Pipeline Snapshot
1414 drugs in pipeline, 6 in Phase 3
| Drug | Indication | Stage | Watch |
|---|---|---|---|
| Pitolisant | Restless Legs Syndrome | Approved | |
| Clemizole HCl + Placebo | Lennox Gastaut Syndrome | Phase 3 | |
| Pitolisant | Prader-Willi Syndrome | Phase 3 | |
| Open-label pitolisant + Double-blind placebo + Double-blind pitolisant | Idiopathic Hypersomnia | Phase 3 | |
| Pitolisant | Idiopathic Hypersomnia | Phase 3 |
Funding History
2Total raised: $164M
FDA Approved Drugs
1Opportunities
Risk Factors
Competitive Landscape
Harmony competes in the narcolepsy market with other wake-promoting agents and in the broader rare neurology space with both large pharma and biotech firms. Its differentiation stems from a patient-centric development model, expertise in rare diseases, and WAKIX's unique mechanism of action for cataplexy.
Company Info
Trading
Contact
Therapeutic Areas
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile